Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 3/2014

01-09-2014 | Original Article

Decreased serum monocytes and elevated neutrophils as additional markers of insulin resistance in type 1 diabetes

Authors: Tomislav Bulum, Branko Kolarić, Lea Duvnjak

Published in: International Journal of Diabetes in Developing Countries | Issue 3/2014

Login to get access

Abstract

Insulin resistance contributes to the high risk for cardiovascular diseases in type 1 diabetes. The differential white blood cell counts predict the future incidence of coronary artery disease. The study evaluated the associations of differential white blood cell count with insulin resistance in type 1 diabetic patients. Study included 353 patients with type 1 diabetes. Insulin sensitivity was measured by estimated glucose disposal rate (eGDR) calculated with the equation: eGDR = 24.31-(12.22xWHR)-(3.29xHT)-(0.57xHbA1c). The units were mgkg−1 min−1; WHR (waist to hip ratio); HT (hypertension). Monocyte count significantly correlated with insulin resistance measured by eGDR (r = 0.10, P = 0.04). Subjects in the upper quartile of the eGDR (>10.87 mgkg−1 min−1) had significantly higher levels of monocyte count (median 6.2 vs 5.4 %, P = 0.02), compared to those in the lowest quartile of eGDR (<7.82 mgkg−1 min−1). In a multiple logistic regression models adjusted for age, sex, duration of diabetes and BMI, monocyte and neutrophil levels were significantly associated with risk of insulin resistance in our subjects (OR = 0.79, and 1.03, P < 0.05). The odd ratios for insulin resistance decreased across baseline monocyte quartiles: 1, 0.75, 0.69, and 0.34. In contrast, odd ratios for insulin resistance increased across baseline neutrophil quartiles: 1, 0.95, 1.60 and 1.99. The significant independent association of monocytes and neutrophils with insulin resistance suggests that activation of the immune system may play a role in the pathogenesis of insulin resistance in type 1 diabetes.
Literature
1.
go back to reference DeFronzo RA, Hendler R, Simonson D. Insulin resistance is a prominent feature of insulin-dependent diabetes. Diabetes. 1982;31:795–801.PubMedCrossRef DeFronzo RA, Hendler R, Simonson D. Insulin resistance is a prominent feature of insulin-dependent diabetes. Diabetes. 1982;31:795–801.PubMedCrossRef
2.
go back to reference Martin FIR, Hopper JL. The relationship of acute insulin sensitivity to the progression of vascular disease in long-term type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1987;24:1–9. Martin FIR, Hopper JL. The relationship of acute insulin sensitivity to the progression of vascular disease in long-term type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1987;24:1–9.
3.
go back to reference Bulum T, Kolarić B, Duvnjak L, Duvnjak M. Nonalcoholic fatty liver disease markers are associated with insulin resistance in type 1 diabetes. Dig Dis Sci. 2011;56:3655–63.PubMedCrossRef Bulum T, Kolarić B, Duvnjak L, Duvnjak M. Nonalcoholic fatty liver disease markers are associated with insulin resistance in type 1 diabetes. Dig Dis Sci. 2011;56:3655–63.PubMedCrossRef
4.
go back to reference Kilpatrick ES, Rigby AS, Atkin SL. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes. Double diabetes in the Diabetes Control and Complications Trial. Diabetes Care. 2007;30:707–12.PubMedCrossRef Kilpatrick ES, Rigby AS, Atkin SL. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes. Double diabetes in the Diabetes Control and Complications Trial. Diabetes Care. 2007;30:707–12.PubMedCrossRef
6.
go back to reference Festa A, D’Agostino RJ, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000;102:42–7.PubMedCrossRef Festa A, D’Agostino RJ, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000;102:42–7.PubMedCrossRef
7.
go back to reference Barbieri M, Ragno E, Benvenutti E, Zito GA, Corsi A, Ferrucci L, et al. New aspects of the insulin resistance syndrome: impact on haematological parameters. Diabetologia. 2001;44:1232–7.PubMedCrossRef Barbieri M, Ragno E, Benvenutti E, Zito GA, Corsi A, Ferrucci L, et al. New aspects of the insulin resistance syndrome: impact on haematological parameters. Diabetologia. 2001;44:1232–7.PubMedCrossRef
8.
go back to reference Hanley AJG, Retnakaran R, Qi Y, Gerstein HC, Perkins B, Raboud J, et al. Association of hematological parameters with insulin resistance and ß-cell dysfunction in nondiabetic subjects. J Clin Endocrinol Metab. 2009;94:3824–32.PubMedCrossRef Hanley AJG, Retnakaran R, Qi Y, Gerstein HC, Perkins B, Raboud J, et al. Association of hematological parameters with insulin resistance and ß-cell dysfunction in nondiabetic subjects. J Clin Endocrinol Metab. 2009;94:3824–32.PubMedCrossRef
9.
go back to reference Libby P, Nathan DM, Abraham K, Brunzell JD, Fradkin JE, Haffner SM, et al. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Disease Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus. Circulation. 2005;111:3489–93.PubMedCrossRef Libby P, Nathan DM, Abraham K, Brunzell JD, Fradkin JE, Haffner SM, et al. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Disease Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus. Circulation. 2005;111:3489–93.PubMedCrossRef
11.
go back to reference Bulum T, Duvnjak L. White blood cell count is independently associated with insulin resistance in type 1 diabetic patients. Diabetes. 2012;61 Suppl 1:A690. Bulum T, Duvnjak L. White blood cell count is independently associated with insulin resistance in type 1 diabetic patients. Diabetes. 2012;61 Suppl 1:A690.
12.
go back to reference Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol. 2004;44:1945–56.PubMedCrossRef Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol. 2004;44:1945–56.PubMedCrossRef
13.
go back to reference Olivares R, Ducimetiere P, Claude JR. Monocyte count: a risk factor for coronary heart disease? Am J Epidemiol. 1993;137:49–53.PubMed Olivares R, Ducimetiere P, Claude JR. Monocyte count: a risk factor for coronary heart disease? Am J Epidemiol. 1993;137:49–53.PubMed
14.
go back to reference Giulietti A, Stoffels K, Decallonne B, Overbergh L, Mathieu C. Monocytic expression behavior of cytokines in diabetic patients upon inflammatory stimulation. Ann NY Acad Sci. 2004;1037:74–8.PubMedCrossRef Giulietti A, Stoffels K, Decallonne B, Overbergh L, Mathieu C. Monocytic expression behavior of cytokines in diabetic patients upon inflammatory stimulation. Ann NY Acad Sci. 2004;1037:74–8.PubMedCrossRef
15.
go back to reference Devaraj S, Glaser N, Griffen S, Wang-Polagruto J, Miguelino E, Jiadal I. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes. 2006;55:774–9.PubMedCrossRef Devaraj S, Glaser N, Griffen S, Wang-Polagruto J, Miguelino E, Jiadal I. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes. 2006;55:774–9.PubMedCrossRef
16.
go back to reference Kunt T, Forst T, Fruh B, Flohr T, Schneider S, Harzer O, et al. Binding of monocytes from normolipidemic hyperglycemic patients with type 1 diabetes to endothelial cells is increased in vitro. Exp Clin Endocrinol Diabetes. 1999;107:252–6.PubMedCrossRef Kunt T, Forst T, Fruh B, Flohr T, Schneider S, Harzer O, et al. Binding of monocytes from normolipidemic hyperglycemic patients with type 1 diabetes to endothelial cells is increased in vitro. Exp Clin Endocrinol Diabetes. 1999;107:252–6.PubMedCrossRef
18.
go back to reference Bouma G, Lam-Tse WK, Wierenga-Wolf AF, Drexhage HA, Versnel MA. Increased serum levels of MRP-8/14 in type 1 diabetes induce an increased expression of CD11b and an enhanced adhesion of circulating monocytes to fibronectin. Diabetes. 2004;53:1979–86.PubMedCrossRef Bouma G, Lam-Tse WK, Wierenga-Wolf AF, Drexhage HA, Versnel MA. Increased serum levels of MRP-8/14 in type 1 diabetes induce an increased expression of CD11b and an enhanced adhesion of circulating monocytes to fibronectin. Diabetes. 2004;53:1979–86.PubMedCrossRef
19.
go back to reference Cipolletta C, Ryan KE, Hanna EV, Trimble ER. Activation of peripheral blood CD14+ monocytes occurs in diabetes. Diabetes. 2005;54:2779–86.PubMedCrossRef Cipolletta C, Ryan KE, Hanna EV, Trimble ER. Activation of peripheral blood CD14+ monocytes occurs in diabetes. Diabetes. 2005;54:2779–86.PubMedCrossRef
20.
go back to reference Dorffel Y, Latsch C, Stuhmuller B, Schrieber S, Scholze S, Burmester DR, et al. Preactivated peripheral blood monocytes in patients with essential hypertension. Hypertension. 1999;34:113–7.PubMedCrossRef Dorffel Y, Latsch C, Stuhmuller B, Schrieber S, Scholze S, Burmester DR, et al. Preactivated peripheral blood monocytes in patients with essential hypertension. Hypertension. 1999;34:113–7.PubMedCrossRef
21.
go back to reference Cifarelli V, Libman IM, DeLuca A, Becker D, Trucco M, Luppi P. Increased expression of monocyte CD11b (Mac-1) in overweight recent-onset type 1 diabetic children. Rev Diabet Stud. 2007;4:113–20.CrossRefPubMedCentral Cifarelli V, Libman IM, DeLuca A, Becker D, Trucco M, Luppi P. Increased expression of monocyte CD11b (Mac-1) in overweight recent-onset type 1 diabetic children. Rev Diabet Stud. 2007;4:113–20.CrossRefPubMedCentral
22.
go back to reference Williams KV, Erbey JR, Becker D, Arsianian S, Orchard TJ. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes. 2000;49:626–32.PubMedCrossRef Williams KV, Erbey JR, Becker D, Arsianian S, Orchard TJ. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes. 2000;49:626–32.PubMedCrossRef
24.
go back to reference Geisler C, Almdal T, Bennedsen J, Rhodes JM, Kolendorf K. Monocyte functions in diabetes mellitus. Acta Pathol Microbiol Immunol Scand. 1982;90:33–7. Geisler C, Almdal T, Bennedsen J, Rhodes JM, Kolendorf K. Monocyte functions in diabetes mellitus. Acta Pathol Microbiol Immunol Scand. 1982;90:33–7.
25.
go back to reference Senn JJ, Klover PJ, Nowak IA, Mooney RA. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes. 2002;51:3391–9.PubMedCrossRef Senn JJ, Klover PJ, Nowak IA, Mooney RA. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes. 2002;51:3391–9.PubMedCrossRef
26.
go back to reference Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004;25:4–7.PubMedCrossRef Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004;25:4–7.PubMedCrossRef
27.
go back to reference Zeyda M, Farmer D, Todoric J, Aszmann O, Speiser M, Györi G, et al. Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes. 2007;31:1420–8.CrossRef Zeyda M, Farmer D, Todoric J, Aszmann O, Speiser M, Györi G, et al. Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes. 2007;31:1420–8.CrossRef
28.
go back to reference Bradshaw EM, Raddassi K, Elyaman W, Orban T, Gottlieb PA, Kent SC, et al. Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells. J Immunol. 2009;183:4432–9.PubMedCrossRefPubMedCentral Bradshaw EM, Raddassi K, Elyaman W, Orban T, Gottlieb PA, Kent SC, et al. Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells. J Immunol. 2009;183:4432–9.PubMedCrossRefPubMedCentral
29.
go back to reference Padmos RC, Schloot NC, Beyan H, Ruwhof C, Staal FJT, de Ridder D, et al. Distinct monocyte gene-expression profiles in autoimmune diabetes. Diabetes. 2008;57:2768–73.PubMedCrossRefPubMedCentral Padmos RC, Schloot NC, Beyan H, Ruwhof C, Staal FJT, de Ridder D, et al. Distinct monocyte gene-expression profiles in autoimmune diabetes. Diabetes. 2008;57:2768–73.PubMedCrossRefPubMedCentral
30.
go back to reference Geerlings SE, Hoepelman AIM. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26:259–65.PubMedCrossRef Geerlings SE, Hoepelman AIM. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26:259–65.PubMedCrossRef
31.
go back to reference Marhoffer W, Stein M, Maeser E, Federlin K. Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care. 1992;15:256–60.PubMedCrossRef Marhoffer W, Stein M, Maeser E, Federlin K. Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care. 1992;15:256–60.PubMedCrossRef
32.
go back to reference Balasoiu D, van Kessel KC, van Kats-Renaud HJ, Collet TJ, Hoepelman AI. Granulocyte function in women with diabetes and asymptomatic bacteriuria. Diabetes Care. 1997;20:392–5.PubMedCrossRef Balasoiu D, van Kessel KC, van Kats-Renaud HJ, Collet TJ, Hoepelman AI. Granulocyte function in women with diabetes and asymptomatic bacteriuria. Diabetes Care. 1997;20:392–5.PubMedCrossRef
33.
go back to reference Collier A, Patrick AW, Hepburn DA, Bell D, Jackson M, Dawes J, et al. Leucocyte mobilization and release of neutrophil elastase following acute insulin-induced hypoglycaemia in normal humans. Diabet Med. 1990;7:506–9.PubMedCrossRef Collier A, Patrick AW, Hepburn DA, Bell D, Jackson M, Dawes J, et al. Leucocyte mobilization and release of neutrophil elastase following acute insulin-induced hypoglycaemia in normal humans. Diabet Med. 1990;7:506–9.PubMedCrossRef
34.
go back to reference Moutschen MP, Scheen AJ, Lefebvre PJ. Impaired immune responses in diabetes mellitus: Analysis of the factors and mechanisms involved in relevance to the increased susceptibility of diabetic patients to specific infections. Diabetes Metab. 1992;18:187–201. Moutschen MP, Scheen AJ, Lefebvre PJ. Impaired immune responses in diabetes mellitus: Analysis of the factors and mechanisms involved in relevance to the increased susceptibility of diabetic patients to specific infections. Diabetes Metab. 1992;18:187–201.
35.
go back to reference Ommen SR, Gibbons RJ, Hodge DO, Thomson SP. Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. Am J Cardiol. 1997;79:812–4.PubMedCrossRef Ommen SR, Gibbons RJ, Hodge DO, Thomson SP. Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. Am J Cardiol. 1997;79:812–4.PubMedCrossRef
36.
go back to reference Ommen SR, Hodge DO, Rodeheffer RJ, McGregor CG, Thomson SP, Gibbons RJ. Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation. 1998;97:19–22.PubMedCrossRef Ommen SR, Hodge DO, Rodeheffer RJ, McGregor CG, Thomson SP, Gibbons RJ. Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation. 1998;97:19–22.PubMedCrossRef
Metadata
Title
Decreased serum monocytes and elevated neutrophils as additional markers of insulin resistance in type 1 diabetes
Authors
Tomislav Bulum
Branko Kolarić
Lea Duvnjak
Publication date
01-09-2014
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 3/2014
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-013-0176-5

Other articles of this Issue 3/2014

International Journal of Diabetes in Developing Countries 3/2014 Go to the issue